Molecular Diagnostics Market is expected to grow at a significant rate during the forecast period 2018-2023. Molecular diagnostics involves the application of a large array of techniques right from molecular biology to conducting a various test for analyzing biological markers in the genome and proteomes. The molecular diagnostic is used to keep close track of infectious disease, it’s monitoring, risks involved and for various other purposes. The applicability of such diagnostic practice is highly in demand owing to the rising trend of personalized treatment and personalized medication. The major factor fueling the growth of the market is a rise in the prevalence of infectious diseases and also increasing cases of cancer across the globe. The demand for a cost-effective and accurate diagnostic solution is another factor propelling the growth of the market. On the contrary, the stringent laws and regulations related is the major factor restraining the growth of the market. The lack of adequate infrastructure in developing countries is one of the major hindrances in the growth of the market in emerging regions. The extended support of the government in terms of funding and technological advancement for the development of more precise and cost-effective diagnostic device will propel the market in future.
Request a free sample of our report on Molecular Diagnostics Market : https://www.omrglobal.com/request-sample/molecular-diagnostics-market
Based on the geography, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. The emerging countries such as India and China in the Asia-Pacific region is expected to grow significantly during the forecast attributed to the rapid development of the healthcare industry in such regions. North America holds the major share in the molecular diagnostics market owing to the presence of a large number of companies both in development and research of molecular diagnostic fields, the region also has the highest statistics related with cancer incidence. The European region follows North America in market share owing to the availability of well-established healthcare facility and increasing demand for personalized treatment.
A full report of Molecular Diagnostics Market is available at : https://www.omrglobal.com/industry-reports/molecular-diagnostics-market
Global Molecular Diagnostics Market Segmentation
By Technology
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Mass Spectrometry (MS)
DNA Microarray
Next-Generation Sequencing (NGS)
Transcription Mediated Amplification
Isothermal Nucleic Acid Amplification
By Product
Testing instruments
Diagnostic Reagents and Kits
By Application
Infectious Diseases
Cancer
Cardiovascular Disease
Genetic Testing
Forensic Science
Neurological Disease
Other (Microbiology)
By End-User
Hospitals
Diagnostic Centres
Research Institute
Competitive Landscape
Key Strategies
Key Company Analysis
Regional Analysis
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
AltheaDX, Inc.
AutoGenomics, Inc.
Beckman Coulter, Inc.
Becton Dickinson and Co.
Biocartis N.V.
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDX, Inc.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/molecular-diagnostics-market
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email:
[email protected]
Contact no: +91 780-304-0404